Regulatory T cells (Treg cells) are crucial modulators of the immune system, maintaining a delicate balance by suppressing overactive immune responses and preventing autoimmunity. However, in the context of Mtb infection, these cells often expand and suppress T cell-mediated antibacterial immunity, facilitating bacterial persistence. The pivotal question that has intrigued immunologists and microbiologists alike is whether Mtb actively manipulates this expansion and functional potentiation of Treg cells or merely benefits passively from the altered immune landscape.

Addressing this question, researchers employed a genome-wide mutant library of Mtb to systematically identify bacterial factors that influence host immune modulation. Their investigations revealed that the bacterial gene Rv1272c, encoding an ATP-binding cassette (ABC) transporter, is upregulated under hypoxic conditions, which mimic the granulomatous environment of infected lung tissue. This upregulation appears to be a survival tactic adopted by Mtb to thrive under oxygen-limited conditions within the host.

Functionally, Rv1272c facilitates the import of lecithin, a phospholipid abundant in host cell membranes. Intriguingly, this import culminates in the bacterial production and subsequent release of linoleic acid, a polyunsaturated fatty acid derived from lecithin metabolism. This metabolite, secreted by infected macrophages, emerges as a critical immunomodulatory molecule in the Mtb-host interaction, acting beyond the classical paradigms of bacterial antigens or secreted proteins.

The investigation into the immunological impact of linoleic acid unveiled a novel pathway: linoleic acid drives increased surface trafficking of cytotoxic T lymphocyte antigen 4 (CTLA-4) on Treg cells. CTLA-4 is a pivotal immune checkpoint molecule known to suppress T cell activation and effector functions. Enhanced CTLA-4 expression on Treg cells effectively reinforces their immunosuppressive capacities, thereby tipping the scale away from bacterial clearance toward immune tolerance.

At the molecular level within Treg cells, linoleic acid exerts its effects via the Ca²⁺ transporter ATP2a3. Binding of linoleic acid promotes the formation of mitochondria-associated endoplasmic reticulum (ER) membranes, critical contact sites that facilitate inter-organelle communication and calcium flux. This interaction enhances calcium transfer from the ER to mitochondria, leading to depletion of ER calcium stores. Subsequently, store-operated calcium entry is triggered, resulting in elevated cytosolic Ca²⁺ concentration.

This sustained increase in intracellular calcium is pivotal in modulating cellular processes, notably the Ca²⁺-dependent trafficking of CTLA-4 to the Treg cell surface. The outcome is a potent augmentation of immune checkpoint signaling, which suppresses macrophage reactive oxygen species (ROS) production—a vital bactericidal mechanism. By dampening these oxidative responses, Mtb gains a survival advantage within the hostile intramacrophage environment.

In vivo experiments substantiated these findings, demonstrating that Mtb strains expressing Rv1272c promoted enhanced CTLA-4 surface expression on Treg cells, correlating with increased bacterial survival. This definitive link between a bacterial metabolite and functional modulation of host immune checkpoints illustrates an unprecedented mode of immune evasion, whereby a pathogen directly manipulates host cell lipid metabolism and calcium signaling to disable immune defenses.

The implications of this discovery extend beyond tuberculosis. It underscores the potential for bacterial metabolites to serve as immunoregulatory agents, shaping the host immune landscape in favor of persistent infection. Furthermore, the detailed mechanistic elucidation of linoleic acid’s engagement with ATP2a3 and the subsequent impact on ER-mitochondria communication spotlights new dimensions in immunometabolic regulation with broad biomedical relevance.

Understanding the molecular chess game between Mtb and host immunity could inspire innovative therapeutic avenues. Targeting the Rv1272c transporter, blocking linoleic acid production, or modulating ATP2a3 function may represent novel strategies to disrupt Mtb’s subversive tactics. Additionally, manipulating CTLA-4 trafficking in Treg cells offers a tantalizing approach to restore robust anti-mycobacterial immunity without compromising peripheral tolerance.

This discovery also accentuates the significance of host-pathogen metabolic interplay, which has emerged as a central theme in infectious disease research. Unlike conventional virulence factors such as toxins or secreted enzymes, metabolites act subtly yet profoundly by reprogramming host cellular circuits. As metabolic crosstalk shapes immune outcomes, pathogen-derived lipids like linoleic acid exemplify molecular agents that subvert host defenses with surgical precision.

Moreover, the study’s use of advanced genetic tools and in vivo models signifies a technical leap forward in unraveling bacterial gene function within the complex host environment. The comprehensive elucidation of Rv1272c’s role under hypoxic stress conditions aligns with the known pathology of granulomas, grounding the findings in physiological relevance that resonates with clinical realities.

The identification of the ER-mitochondria interface as a crucial nexus in Treg cell function adds an intriguing layer to the understanding of immune regulation. Calcium signaling between these organelles influences not only metabolic and apoptotic pathways but now emerges as a determinant of immune checkpoint expression. This crosstalk serves as a poignant reminder of the interconnectedness of cellular systems, where metabolic flux governs immunological fate.

This research invites renewed scrutiny of the role of fatty acids in immune modulation. While linoleic acid is a common dietary polyunsaturated fatty acid, its derivation from an intracellular bacterium to manipulate Treg cells is a striking demonstration of evolutionary adaptation. The prospect that dietary or endogenous fatty acid pools could influence infectious disease outcomes warrants further exploration.

The study’s broader implications resonate with the ongoing quest to understand chronic infections and immune tolerance. If pathogens like Mtb can exploit immune checkpoints and metabolic signaling, similar mechanisms might underpin other persistent infections, autoimmune diseases, or even cancer immune evasion strategies. Translating these insights into clinical practice could transform approaches to vaccine design and immunotherapy.

In conclusion, this seminal work illuminates a novel metabolic dimension of Mtb pathogenesis, where bacterial-derived linoleic acid commandeers host Treg cell function to promote intracellular bacterial survival. By co-opting calcium signaling pathways and boosting CTLA-4 trafficking, Mtb achieves immune suppression that enables its chronic persistence. This remarkable example of host-pathogen interplay advances understanding of tuberculosis immunobiology and inspires innovative therapeutic strategies to combat this global health burden.

Subject of Research: Mycobacterium tuberculosis immune evasion mechanisms; immunometabolic regulation of regulatory T cells during infection.

Article Title: Mycobacterium tuberculosis-derived linoleic acid increases regulatory T cell function to promote bacterial survival within macrophages.

Article References:
Cheng, H., Li, S., Liu, H. et al. Mycobacterium tuberculosis-derived linoleic acid increases regulatory T cell function to promote bacterial survival within macrophages. Nat Microbiol (2025). https://doi.org/10.1038/s41564-025-02140-2

Image Credits: AI Generated

The ATP-binding cassette (ABC) transporters represent a large family of proteins responsible for translocating various substrates across cellular membranes utilizing ATP hydrolysis. Abcc5/MRP5, expressed abundantly in neural tissue, had long been hypothesized to contribute primarily to the efflux of organic anions and nucleoside analogues. However, the recent data suggest that its functional repertoire extends into realms crucial for neuronal communication and plasticity. This paradigm shift underscores the interconnectedness of membrane transport mechanisms with synaptic physiology and behavioral outputs.

Central to the study’s narrative is memory consolidation, the fundamental process by which transient experiences are forged into long-lasting memories. Through a combination of genetic, electrophysiological, and behavioral assays performed on murine models deficient in Abcc5, the research team demonstrated clear impairments in both short- and long-term memory paradigms. Intriguingly, these deficits correlated not only with altered neurotransmitter dynamics but also with disruption in gene expression patterns associated with synaptic remodeling. This implicates Abcc5 as a critical integrator of signaling events necessary for the stabilization of memory engrams.

Circadian rhythms, the endogenous oscillations governing physiological and behavioral cycles, are finely tuned by a network of molecular clocks and environmental cues. The study uncovered a hitherto unrecognized role for Abcc5 in the regulation of these rhythms. Mice bearing targeted deletions of Abcc5 exhibited aberrant locomotor activity patterns, desynchronization of core clock gene expression in the suprachiasmatic nucleus, and altered melatonin secretion profiles. These findings highlight that beyond its transporter function, Abcc5 may modulate circadian homeostasis by influencing signaling pathways linked to neuronal excitability and rhythmic gene transcription.

Glutamatergic neurotransmission, mediated primarily by the excitatory neurotransmitter glutamate, forms the backbone of synaptic communication in the central nervous system. Banks and colleagues provided compelling evidence that Abcc5 regulates aspects of glutamate signaling, notably through its impact on glutamate receptor trafficking and synaptic vesicle cycling. Electrophysiological recordings revealed diminished excitatory postsynaptic potentials and impaired long-term potentiation (LTP) in hippocampal slices derived from Abcc5 knockout animals. These functional impairments dovetail with the cognitive deficits observed in vivo, reinforcing the transporter’s role in sustaining synaptic plasticity.

Delving into the molecular underpinnings, the researchers employed advanced proteomic analyses and identified disrupted clustering of NMDA and AMPA receptor subunits in the absence of Abcc5. Such alterations compromise synaptic strength and adaptability, integral components of memory encoding processes. Moreover, the team observed altered levels of intracellular signaling molecules such as CaMKII and CREB, which are well-established mediators of activity-dependent gene expression pertinent to learning and memory.

The link between Abcc5 function and circadian signaling was further explored through transcriptomic profiling, which revealed misexpression of clock genes including Per1, Cry1, and Bmal1. These deviations suggest that Abcc5 might be necessary for the precise temporal control of gene expression cycles that orchestrate physiological rhythms. Additionally, altered redox states and ATP availability observed in mutant mice point towards a metabolic dimension to Abcc5’s regulatory role, integrating energy dynamics with circadian biochemical cascades.

Of particular significance is the potential translational implication of these findings. Disruptions in memory consolidation and circadian dysregulation are hallmark features of numerous neuropsychiatric conditions such as Alzheimer’s disease, schizophrenia, and mood disorders. By identifying Abcc5 as a nodal point connecting these processes, the study beckons the development of pharmacological modulators aimed at optimizing transporter activity. Such interventions could restore synaptic efficacy and stabilize biological rhythms, offering multifactorial remediation for cognitive and affective symptoms.

The research also opens exciting avenues for the study of drug resistance phenomena in psychiatric treatment. Given that ABC transporters are known to influence the pharmacokinetics of many neuroactive compounds, Abcc5 might serve as a bridge linking membrane transporter function with therapeutic outcomes. Understanding this relationship could refine dosing protocols and improve the efficacy of existing medications targeting glutamatergic pathways or circadian regulators.

Methodologically, the study’s strength lies in its integrative approach, combining in vivo behavioral assessments with exhaustive molecular characterizations. Techniques such as in situ hybridization, high-resolution microscopy, and patch-clamp electrophysiology provided a comprehensive picture of how genetic ablation of Abcc5 culminates in altered neuronal circuits and behavioral phenotypes. This multi-tiered strategy established causal links rather than mere associations, strengthening the validity of the conclusions drawn.

Furthermore, the work contributes novel insights into the intracellular trafficking roles played by ABC transporters in neurons, a comparatively underexplored aspect of their function. The authors propose a model whereby Abcc5 participates in the recycling and surface expression of key synaptic proteins, potentially influencing receptor availability and synaptic strength. This mechanistic framework invites broader examination across other members of the ABC transporter family and their involvement in neural dynamics.

Notably, the discoveries elucidate how peripheral and central functions of transporters such as Abcc5 are intertwined. While traditionally associated with xenobiotic clearance and cellular protection, this study places Abcc5 squarely in the domain of neurophysiology, underscoring the protein’s dualistic nature. Understanding these diverse roles will be critical as the field moves toward precision medicine approaches in neurology and psychiatry.

The implications for circadian biology are equally profound. As global lifestyles increasingly encroach upon natural rhythms, understanding molecular players like Abcc5 that govern the internal clock becomes ever more pressing. The transporter’s influence on rhythmic gene expression and behavioral patterns suggests it might also mediate the impact of environmental stressors on circadian stability, providing a molecular target for interventions aimed at circadian misalignment.

In conclusion, the work by Banks et al. presents a compelling narrative that redefines the functional landscape of the Abcc5 ATP-binding cassette transporter within the mammalian brain. By bridging the realms of memory, circadian biology, and synaptic signaling, these findings propel Abcc5 from a peripheral actor to a central orchestrator of neural health and behavior. Future research focused on this transporter could unveil transformative strategies to combat cognitive decline and circadian disturbances associated with neuropsychiatric illnesses, heralding a new era in brain therapeutics.

Subject of Research: The role of the murine ATP-binding cassette transporter C5 (Abcc5/MRP5/cMOAT) in memory consolidation, circadian rhythm regulation, and glutamatergic signaling.

Article Title: The murine ATP-binding cassette transporter C5 (Abcc5/MRP5/cMOAT) plays a role in memory consolidation, circadian rhythm regulation and glutamatergic signalling.

Article References: Banks, G., Cyranka, M., Vedovato, N. et al. The murine ATP-binding cassette transporter C5 (Abcc5/MRP5/cMOAT) plays a role in memory consolidation, circadian rhythm regulation and glutamatergic signalling. Transl Psychiatry 15, 218 (2025). https://doi.org/10.1038/s41398-025-03438-9

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s41398-025-03438-9

Nrf2 has long been recognized for its critical role in maintaining cellular redox homeostasis. By regulating the expression of antioxidant genes through the antioxidant response element (ARE), Nrf2 protects normal cells from oxidative damage and environmental toxins. However, in the context of malignancy, this protective mechanism takes on a sinister role. In osteosarcoma cells, aberrant activation and overexpression of Nrf2 establish a survival advantage, safeguarding tumor cells from the cytotoxic effects of chemotherapy and radiotherapy.

One of the principal ways Nrf2 mediates chemoresistance is through the modulation of intracellular drug concentration. It achieves this by inducing the expression of drug transporter proteins belonging to the ATP-binding cassette (ABC) family and reduced folate carrier (RFC) proteins. These efflux pumps effectively lower the accumulation of chemotherapeutic agents such as cisplatin, doxorubicin, and methotrexate within cancer cells, thereby diminishing drug efficacy. This mechanism is further compounded by Nrf2’s ability to enhance cellular detoxification pathways, enabling malignant cells to neutralize and eliminate harmful compounds more efficiently.

Beyond drug resistance, Nrf2 orchestrates a robust defense against radiotherapy-induced oxidative stress. Ionizing radiation primarily exerts its tumoricidal effect by generating reactive oxygen species (ROS), which inflict DNA damage and promote cell death. Elevated Nrf2 activity in osteosarcoma cells boosts the production of antioxidant enzymes and DNA repair machinery, allowing these cells to swiftly mitigate ROS damage and repair lethal DNA double-strand breaks. This concerted response not only preserves tumor cell viability but also fosters radioresistance, undermining clinical treatment outcomes.

The intricate regulatory network surrounding Nrf2 involves critical signaling pathways that contribute to osteosarcoma pathophysiology. The Keap1-Nrf2-ARE axis, a well-characterized molecular sensor of oxidative stress, becomes dysfunctional in resistant tumors, leading to persistent Nrf2 activation. Meanwhile, crosstalk with the PI3K/AKT pathway amplifies survival signals and promotes metabolic remodeling, further supporting malignant progression. Autophagy, a cellular recycling process, is also modulated by Nrf2, balancing tumor cell survival and death while influencing susceptibility to therapy. Moreover, emerging evidence highlights interactions between Nrf2 and regulated cell death mechanisms like ferroptosis, underscoring its role not only as a protector but also as a modulator of tumor fate decisions.

Crucially, Nrf2’s influence extends beyond survival pathways to govern tumor proliferation and metastasis. Osteosarcoma cells with upregulated Nrf2 demonstrate metabolic reprogramming favoring anabolic growth and adaption to nutrient-deprived microenvironments. This metabolic flexibility, combined with Nrf2’s promotion of epithelial-to-mesenchymal transition (EMT), facilitates tumor dissemination and secondary colonization. Clinical data correlates high Nrf2 expression levels with poorer patient prognoses and reduced overall survival, firmly establishing its oncogenic potential.

Targeting Nrf2 therapeutically is a daunting endeavor due to its indispensable role in protecting normal tissues from oxidative injury. Nonetheless, the discovery of selective inhibitors such as ML385, which disrupt the Nrf2 pathway, offers a promising avenue to sensitize osteosarcoma cells to conventional therapies. Additionally, natural compounds like oridonin have exhibited efficacy in preclinical models by dampening Nrf2-mediated resistance mechanisms and inducing tumor regression. These approaches symbolize the pioneering efforts to exploit tumor-specific vulnerabilities while minimizing collateral damage.

The quest to unravel the multilayered functions of Nrf2 underscores a paradigm shift in understanding osteosarcoma biology. It invites a nuanced appreciation that while antioxidant defense is vital for physiological homeostasis, its hijacking by cancer cells represents a formidable barrier to treatment success. As research intensifies, focusing on the molecular intricacies of Nrf2 regulation and interaction networks may unlock innovative therapeutic strategies tailored for resistant osteosarcoma subtypes.

Further investigations into the role of Nrf2 in modulating autophagy, ferroptosis, and metabolic plasticity will be critical. These studies promise to delineate the balance between tumor suppression and promotion exerted by Nrf2, guiding the design of combination therapies that strategically disrupt survival pathways. Meanwhile, advancements in drug delivery systems and precision medicine hold potential to translate Nrf2-targeted interventions from bench to bedside.

Ultimately, these insights herald a new era in combating osteosarcoma. By deciphering the molecular underpinnings driving chemoradiotherapy resistance, the scientific community paves the way for more effective and personalized treatment regimens. Harnessing the knowledge of Nrf2’s double-edged impact may revolutionize clinical outcomes for pediatric patients battling this aggressive malignancy, offering hope for improved survival and quality of life.

—

Subject of Research: Chemoradiotherapy resistance mechanisms in osteosarcoma focused on the role of Nuclear factor E2-related factor 2 (Nrf2).

Article Title: Nrf2: A key regulator in chemoradiotherapy resistance of osteosarcoma

News Publication Date: 2024

Web References:
http://dx.doi.org/10.1016/j.gendis.2024.101335

References:
Xianglin Peng, Jing Feng, Han Yang, Ping Xia, Feifei Pu, Nrf2: A key regulator in chemoradiotherapy resistance of osteosarcoma, Genes & Diseases, Volume 12, Issue 4, 2025, 101335.

Image Credits: Genes & Diseases

Keywords: Osteosarcoma, Nrf2, chemoradiotherapy resistance, antioxidant response element, drug efflux, DNA repair, reactive oxygen species, Keap1-Nrf2-ARE pathway, PI3K/AKT signaling, autophagy, ferroptosis, tumor proliferation, metastasis